Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Nutra Pharma Corp. (NPHC) is fighting for Myasthenia Gravis Sufferers with its Orphan Drug Application for RPI-78M

Nutra Pharma Corp. (OTCQB: NPHC) hasn’t forgotten about the sufferers of myasthenia gravis (MG). The Coral Springs, Florida-based company announced in December 2015 that it had applied for Orphan Status from the Food and Drug Administration (FDA) for its RPI-78M treatment for MG. RPI-78M, described as modified a-cobra toxin in the FDA Orphan Drug database, […]

GTX Corporation’s (GTXO) GPS SmartSole Technology Highlighted in Friendship Circle Article

GTX Corporation’s (OTC: GTXO) GPS SmartSole was the focus of a recent article highlighting the latest innovations in wearable tracking devices. The piece, titled “GPS SmartSole Gives Peace of Mind to Parents of Wanderers,” introduces readers to the considerable benefits of the GPS SmartSole, an invisible wearable technology device intended for non-invasive tracking of individuals […]

Moxian, Inc. (MOXC) Announces Exclusive Development Partnership with Xinhua Media Affiliate

Earlier today, Moxian, Inc. (OTCQB: MOXC) announced that its subsidiary, Moxian Technologies (Beijing) Co. Ltd., has entered into an exclusive development partnership with Xinhua New Media Culture Communication Co. Ltd. Through this partnership, Moxian will serve as the exclusive seller of advertising space for Xinhua’s popular gaming platform, the Xinhua New Media App. Per the […]

International Stem Cell Corp. (ISCO) Developing Therapeutic Products from Its Own Intellectual Property

As part of its quest to successfully develop stem cells for research and therapy, the International Stem Cell Corporation (OTCQB: ISCO) has been using a powerful new stem cell technology to address the problem of immune-rejection. Most recently, the Carlsbad, California-based company has been focused on utilizing parthenogenesis to advance the field of regenerative medicine. […]

Content Checked Holdings, Inc. (CNCK) Updates Investors through Release of CEO’s Letter to Shareholders

Earlier today, Content Checked Holdings, Inc. (OTCQB: CNCK) announced the release of a letter from the company’s chief executive office, Kris Finstad, regarding the current status of the company and other important developments. The letter detailed a number of milestones – including Content Checked’s recent revenue growth, formation of a board of advisors and new […]

Avant Diagnostics, Inc. (AVDX) Announces Letter of Intent to Merge with Diagnostics Division of Amarantus Bioscience Holdings, Inc.

Earlier today, Avant Diagnostics, Inc. (OTCQB: AVDX) announced that it has entered into a non-binding letter of intent to merge with Amarantus Diagnostics, a wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc. (OTCQX: AMBS). Under the terms of the agreement, Avant will issue 80 million shares of common stock to Amarantus upon execution of definitive agreements, […]

Cherubim Interests, Inc. (CHIT) Adds Fresh Faces to its Already Seasoned Business Team

An alternative construction company, Cherubim Interests, Inc. (OTC: CHIT) invests in undervalued real estate properties for the purpose of improvement. The company seeks alternative, single, multifamily, and commercial dwellings for purchase then covers each step in the development process from due diligence to property management. Cherubim Interests aims to improve communities while providing high returns […]

 

From Our Blog

HeartBeam Inc. (NASDAQ: BEAT) Advances Power of ECG with High-Fidelity At-Home Heart-Monitoring System

September 10, 2025

For decades, the traditional 12-lead electrocardiogram (“ECG”) has been the gold standard in cardiac diagnostics, including arrhythmia assessment, offering a comprehensive assessment of the heart’s electrical activity. However, traditional 12-lead ECG systems often come with limitations such as cumbersome setups and restricted accessibility. HeartBeam (NASDAQ: BEAT) is addressing these challenges by developing the HeartBeam System, the first […]

Rotate your device 90° to view site.